Sanofi
SNYNF
|
$92.966
630
|
Health Technology
(0.0% 1d) (-2.0% 1m) (-15.5% 1y) (0.0% 2d) (0.0% 3d) (-1.4% 7d) (-28.39% volume)
Earnings Calendar:
Market Cap: $ 116,969,009,235
http://www.sanofi.com
Sec Filling | Patents | n/a employees
(FR) Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine diabetic diabetes cardiovascular
add to watch list Paper trade email alert is off
Press-releases
Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer (CMO)
Published: 2024-04-16 (Crawled : 00:00) - prnewswire.com
SNY | $45.99 0.13% 70K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 630
|
Health Technology
| Email alert
Add to watchlist
medical
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
NVS | $92.69 -1.82% 100K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
set therapeutics market
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | $92.966 630
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | $144.84 -1.86% 3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $163.08 0.87% 500K
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | $45.99 0.13% 70K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Published: 2024-04-15 (Crawled : 05:00) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
SNY | $45.99 0.13% 70K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
drug als biomarker
Sanofi: Information concerning the total number of voting rights and shares - March 2024
Published: 2024-04-12 (Crawled : 18:00) - globenewswire.com
SNY | $45.99 0.13% 70K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 630
|
Health Technology
| Email alert
Add to watchlist
total
AstraZeneca Expands Fasenra’s Label to Children Aged 6 to 11 with Severe Asthma
Published: 2024-04-12 (Crawled : 12:00) - biospace.com/
SNY | $45.99 0.13% 70K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
label children astrazeneca
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
SNY | $45.99 0.13% 70K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
label children astrazeneca
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO A | $29.885 -0.81% 54K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -2.94%
JNJ | $144.84 -1.86% 3M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
ABT | $108.85 -0.04% 860K
|
Health Technology
|
| O: -1.06%
H: 0.21%
C: -1.05%
SNY | $45.99 0.13% 70K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
drug label astrazeneca expansion for kids
MPM BioImpact Appoints Frank Neumann, M.D., Ph.D., Distinguished Expert in Clinical Development, as Entrepreneur Partner
Published: 2024-04-11 (Crawled : 12:00) - mpmcapital.com
SNYNF | $92.966 630
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: -0.54%
VSTM | $11.04 -0.27% 2.6K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | $45.99 0.13% 70K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
SNYNF | $92.966 630
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: -0.54%
RLYB | $1.865 1.91% 140K
|
|
| O: 104.91%
H: 0.0%
C: 0.0%
JNJ | $144.84 -1.86% 3M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
VXRT | $0.8755 -3.7% 190K
|
Health Technology
|
| O: 0.0%
H: 2.97%
C: 2.97%
TXMD | $1.9899 29K
|
Health Technology
|
| O: -0.47%
H: 0.48%
C: -0.95%
SNY | $45.99 0.13% 70K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
PTCT | $25.71 0.12% 82K
|
Health Technology
|
| O: 2.01%
H: 1.35%
C: -0.18%
NKTR | $1.525 -2.87% 250K
|
Health Technology
|
| O: 8.53%
H: 25.0%
C: 12.86%
MOR | $18.02 30K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
GLPG | $29.51 -0.97% 63K
|
Health Technology
|
| O: 0.55%
H: 0.29%
C: -1.41%
AMRN | $0.915 -0.39% 190K
|
Health Technology
|
| O: 0.0%
H: 0.96%
C: -1.92%
GOOGL | $154.54 -0.21% 4.9M
|
Technology Services
|
| O: 0.49%
H: 1.77%
C: 1.59%
GOOG | $156.2 -0.08% 3.3M
|
Technology Services
|
| O: 0.43%
H: 1.76%
C: 1.55%
OCX | $2.58 1.98% 54K
|
Health Technology
|
| O: -1.62%
H: 4.43%
C: 3.67%
biopharma novartis
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 48% | 52% |
Top 10 Gainers
TPET | $0.4801 107.75% 16M
|
n/a
JAGX | $0.23 93.6% 310M
|
Health Technology
WISA 4 | $3.17 81.14% 36M
|
Electronic Technology
PALI | $7.41 78.13% 14M
|
Manufacturing
SPCB | $0.4278 55.0% 17M
|
Electronic Technology
BTTR | $7.61 49.22% 1.8M
|
Manufacturing
PRSO | $1.79 40.95% 25M
|
Manufacturing
DYNT | $0.5203 40.47% 17M
|
Health Technology
MCBC | $13.84 39.38% 450K
|
Finance
SNGX | $0.5155 33.52% 3.9M
|
Health Technology
Last 48 Hours Insiders Buying
RMCF | $3.6492 3.6K
|
Consumer Non-Durables
|
20:10